A detailed history of Kapstone Financial Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kapstone Financial Advisors LLC holds 510 shares of LLY stock, worth $454,445. This represents 0.3% of its overall portfolio holdings.

Number of Shares
510
Previous 465 9.68%
Holding current value
$454,445
Previous $362 Million 27.64%
% of portfolio
0.3%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $32,619 - $40,906
45 Added 9.68%
510 $462 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $244,213 - $287,895
465 New
465 $292 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kapstone Financial Advisors LLC Portfolio

Follow Kapstone Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapstone Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kapstone Financial Advisors LLC with notifications on news.